David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 27,746 shares at $27.31 ($758K) on 2025-01-21, disclosed to the SEC on 2025-01-22.
Seasonal sale ($758k) by SVP, Life Sciences — this insider has traded PHR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.31 | 13,873 | $379K | 50.0% |
| 2 | $27.31 | 13,873 | $379K | 50.0% |
| Total | $27.31 avg | 27,746 | $758K | 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |